 the
most appropriate therapy. When the risk of intervention is
sufficiently increased due to the presence of one or more of
these factors, medical therapy may be more appropriate
than CEA or CAS.
In the initial CAS trials, a series of anatomic and
physiologic criteria were developed by a consensus panel
in an attempt to identify “high-risk” CEA patients who
might be expected to benefit from CAS.192 Although
these criteria were used to enroll